Enrichment analysis shows that SLC35C1 may act mainly through signaling pathways such as TNFA_SIGNALING_VIA_NFKB, GLYCOLYSIS, and APICAL_JUNCTION thus affecting glioma development and progression. This evidence concerns the gene SLC35C1 and central nervous system cancer.